Cardiovascular leaders should incorporate three important tools as part of a comprehensive CVD prevention program.
Editor's Note: This article originally appeared on ECG's website.
Nearly half of all cardiovascular-related deaths occur without overt warning—a sobering statistic that gives rise to heart disease’s grim nickname as “the silent killer” and highlights the true challenge of prevention and underdiagnosis.1
- As a country, we spend nearly $1 billion a day trying to manage the implications of cardiovascular disease (CVD).2
- Forty-seven percent of all American adults have at least one key risk factor for CVD.3
- Demand for CVD care continues to outpace the number of practicing cardiologists.4
With data suggesting that CVD will continue to increase significantly in the coming years, our current approach to combating the nation’s leading cause of death is unsustainable. What we need is a greater emphasis on prevention and early detection.
A Shifting Landscape
Historically, CV program leaders have focused on expanding invasive and interventional clinical services—which yield high revenue and margins—as part of their strategic growth efforts. However, as a result of advances in technology, innovation, and consumer preference, the landscape of CV care delivery is beginning to shift away from high-cost episodic care toward prevention and personalized care. These advancements have also improved the tools and treatments available to providers for screening and diagnosing patients. Click here to continue>>
News From Our Partners